-

$undefined

N/A

(N/A)

OptiNose NASDAQ:OPTN Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. and Norway.

Location: 1020 Stony Hill Rd Ste 300, Pennsylvania, 19067-5539, US | Website: www.optinose.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

155.3M

Cash

91.36M

Avg Qtr Burn

-8.809M

Short % of Float

9.17%

Insider Ownership

5.99%

Institutional Own.

77.43%

Qtr Updated

06/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
XHANCE (fluticasone propionate) Details Nasal polyps, Chronic sinusitis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XHANCE (fluticasone propionate) Details Chronic sinusitis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.